Eigen develops medical imaging devices for health diagnostic and therapy, with a focus on bridging the gaps between Radiology, Urology, and Oncology. With a strong presence in the scientific and medical communities, Eigen is at the forefront of emerging technology for detecting, localizing, and managing prostate cancer. The company holds numerous patents and adheres to the highest standards in medical device regulatory compliance. Eigen's ISO 13485 certification allows them to pursue sales and distribution in various countries, including Canada, EU countries, and India. With over 30 years of experience, Eigen is a leader in cardiology and radiology imaging and is now pioneering 3D real-time display technology for urologists to view and biopsy the prostate.